Vivalink, a provider of digital healthcare solutions, announces the commercial release of its new wearable ECG sensor adhesive that improves the detection of p-waves during ambulatory cardiac monitoring.
P-wave abnormalities are strong predictors of future adverse cardiac events, including atrial fibrillation, ischemic stroke, and even sudden cardiac death. As a newly introduced companion to Vivalink’s rechargeable, re-usable multi-vital ECG patch, the adhesive is a critical enhancement to Vivalink’s wearable monitors, supporting earlier intervention, improved patient outcomes, and high-quality data collection in clinical trials.
Key features of the upgraded adhesive
Modified Lead 1 placement to enhance p-wave visibility
Single-use, seven-day wear time with water resistance
Contoured design for maximum flexibility of movement
Optimized for both comfort and data integrity
Validated for use in remote and in-person clinical trial settings
Worn vertically on the center chest above the sternum, the adhesive increases p-wave signal detection by up to 160%. P-waves, which represent the electrical activity of the heart’s upper chambers, are important markers of atrial health. Subtle changes in their shape or size can be early indicators of atrial disease, making clear signal capture vital for clinical decision-making in arrhythmias and atrial fibrillation risk, and strengthens the reliability of trial data.
New adhesive advances the accuracy and reliability of cardiac monitoring
The design of the adhesive leverages VivaLink’s patented eSkinTM technology for unparalleled user comfort and flexibility. It is the latest member of the family of adhesives that can be attached to Vivalink’s multi-vital ECG patch achieving world-leading patient wearing experience.
Vivalink’s multi-vital ECG patch is a lightweight, wearable cardiac monitor built for continuous ECG monitoring in clinical care, remote patient monitoring and clinical research environments. Reusable and chargeable, the patch streams live ECG and vital signs such as heart rate, respiratory rate, and skin temperature while also storing data locally to prevent gaps in the event of a network disruption. With up to two weeks of use between charges and a comfortable design, the patch allows for long-term monitoring without disrupting patients’ daily activities.
“Continual innovation in wearable monitoring technology is at the core of our mission,” said Jiang Li, CEO of Vivalink. “By improving p-wave signal clarity, this new adhesive advances the accuracy and reliability of cardiac monitoring. The result is better support for clinicians in identifying arrhythmias early, while easing the burden on patients through comfortable, long-term use in ambulatory settings, hospital-at-home programs and clinical trials that demand accurate ECG data.”
加載中...
